Skip to content

Targeted Intervention for Bipolar Smokers

Targeted Intervention for Bipolar Smokers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01550029
Enrollment
50
Registered
2012-03-09
Start date
2010-07-31
Completion date
2014-08-31
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Nicotine Dependence

Keywords

Smoking, Tobacco, Nicotine, Bipolar

Brief summary

The purpose of this research is to develop and test a new type of smoking cessation counseling for individuals with bipolar disorder.

Detailed description

All participants will receive the nicotine patch, an FDA-approved smoking cessation medication, in an open-label fashion. In addition to the nicotine patch, participants will be randomized to receive one of the two types of counseling for smoking cessation. Participants will be in the research study for approximately 18 weeks. The total number of study visits is 15.

Interventions

BEHAVIORALCounseling/Healthy Lifestyle

A trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting and to help develop knowledge and skills for quitting. Also, the National Cancer Institute's Clearing the Air guide to smoking cessation will be given to subjects. Some specific areas of focus for this intervention are developing a better understanding of reasons for smoking and the consequences of tobacco use and identifying ways for establishing a healthier lifestyle.

BEHAVIORALCounseling/Managing Mood

A trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting smoking and to help develop knowledge and skills for quitting. Also, subjects will receive the National Cancer Institute's Clearing the Air guide to smoking cessation. Some specific areas of focus for this intervention are managing negative moods without smoking and overcoming other obstacles to quitting.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants who are motivated to quit smoking * Male or female * 18 years of age or older * Diagnosed with bipolar disorder according to DSM-IV criteria * Stable on medication with no significant changes in the last 3 months before enrollment. * Smoking 10 cigarettes/day for the past 90 days

Exclusion criteria

* Healthy volunteers * Patients not meeting the criteria for the diagnosis of Bipolar Disorder according to DSM-IV criteria * Not being and being treated with medication for the bipolar disorder

Design outcomes

Primary

MeasureTime frameDescription
Prolonged Abstinence from SmokingLast four weeks of treatment periodConfirmed prolonged abstinence from smoking during the last 4 weeks of the treatment period.

Secondary

MeasureTime frameDescription
Prevalence of Abstinence from SmokingLast 7 days of treatment periodPrevalence abstinence will be assessed during the last 7 days of treatment period, 7 days prior to follow-up visit.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026